These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35639173)

  • 1. Association between non-alcoholic fatty liver disease and bone turnover markers in southwest China.
    Liu Y; Shuai P; Liu Y; Li D
    J Bone Miner Metab; 2022 Jul; 40(4):712-719. PubMed ID: 35639173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between
    Liu Y; Li D; Liu Y; Shuai P
    Front Med (Lausanne); 2021; 8():764472. PubMed ID: 35004736
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.
    Mantovani A; Sani E; Fassio A; Colecchia A; Viapiana O; Gatti D; Idolazzi L; Rossini M; Salvagno G; Lippi G; Zoppini G; Byrne CD; Bonora E; Targher G
    Diabetes Metab; 2019 Sep; 45(4):347-355. PubMed ID: 30315891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis.
    Fang D; Yin H; Ji X; Sun H; Zhao X; Bi Y; Gu T
    Diabetes Metab; 2023 Mar; 49(2):101397. PubMed ID: 36283619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalassemic osteopathy: a new marker of bone deposition.
    Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
    Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of bone turnover markers after elderly hip fracture surgery.
    Li XP; Li XY; Yang MH; Zhu SW; Wu XB; Zhang P
    J Bone Miner Metab; 2021 Mar; 39(2):237-244. PubMed ID: 32876727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients.
    Díez Rodríguez R; Ballesteros Pomar MD; Calleja Fernández A; Calleja Antolin S; Cano Rodríguez I; Linares Torres P; Jorquera Plaza F; Olcoz Goñi JL
    Nutr Hosp; 2014 Dec; 30(6):1256-62. PubMed ID: 25433106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between Serum Bone Turnover Markers and Estimated Glomerular Filtration Rate in Chinese Patients with Diabetes.
    Zhu X; Zhou Y; Hong S; Xue Y; Cui Y
    Dis Markers; 2021; 2021():6731218. PubMed ID: 33505536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of adiposity indices with bone density and bone turnover in the Chinese population.
    Wang J; Yan D; Hou X; Chen P; Sun Q; Bao Y; Hu C; Zhang Z; Jia W
    Osteoporos Int; 2017 Sep; 28(9):2645-2652. PubMed ID: 28555285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men.
    Deng H; Dai Y; Lu H; Li SS; Gao L; Zhu DL
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1457-1462. PubMed ID: 29565507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
    Shimizu M; Suzuki K; Kato K; Jojima T; Iijima T; Murohisa T; Iijima M; Takekawa H; Usui I; Hiraishi H; Aso Y
    Diabetes Obes Metab; 2019 Feb; 21(2):285-292. PubMed ID: 30178600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone metabolism in cholestatic children before and after living-related liver transplantation--a long-term prospective study.
    Kryskiewicz E; Pawlowska J; Pludowski P; Ismail H; Karczmarewicz E; Teisseyre M; Skorupa E; Ryzko J; Kalicinski P; Socha J; Lorenc RS
    J Clin Densitom; 2012; 15(2):233-40. PubMed ID: 22154432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover markers are differentially affected by pre-analytical handling.
    Christensen GL; Halgreen JR; Milenkovski M; Köse A; Quardon N; Jørgensen NR
    Osteoporos Int; 2019 May; 30(5):1137-1141. PubMed ID: 30680430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
    Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
    Marques EA; Gudnason V; Sigurdsson G; Lang T; Johannesdottir F; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
    Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
    Yu XY; Song XX; Tong YL; Wu LY; Song ZY
    Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose.
    Maagensen H; Junker AE; Jørgensen NR; Gluud LL; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2018 May; 103(5):2042-2049. PubMed ID: 29506157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
    Behairy MA; Sherief AF; Hussein HA
    Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.